Works matching IS 10870156 AND DT 2011 AND VI 29 AND IP 2


Results: 36
    1
    2
    3

    A TALE nuclease architecture for efficient genome editing.

    Published in:
    Nature Biotechnology, 2011, v. 29, n. 2, p. 143, doi. 10.1038/nbt.1755
    By:
    • Miller, Jeffrey C.;
    • Siyuan Tan;
    • Guijuan Qiao;
    • Barlow, Kyle A.;
    • Jianbin Wang;
    • Xia, Danny F.;
    • Xiangdong Meng;
    • Paschon, David E.;
    • Elo Leung;
    • Hinkley, Sarah J.;
    • Dulay, Gladys P.;
    • Hua, Kevin L.;
    • Ankoudinova, Irina;
    • Cost, Gregory J.;
    • Urnov, Fyodor D.;
    • Zhang, H. Steve;
    • Holmes, Michael C.;
    • Lei Zhang;
    • Gregory, Philip D.;
    • Rebar, Edward J.
    Publication type:
    Article
    4
    5
    6

    Expression of therapeutic proteins after delivery of chemically modified mRNA in mice.

    Published in:
    Nature Biotechnology, 2011, v. 29, n. 2, p. 154, doi. 10.1038/nbt.1733
    By:
    • Kormann, Michael S. D.;
    • Hasenpusch, Günther;
    • Aneja, Manish K.;
    • Nica, Gabriela;
    • Flemmer, Andreas W.;
    • Herber-Jonat, Susanne;
    • Huppmann, Marceline;
    • Mays, Lauren E.;
    • Illenyi, Marta;
    • Schams, Andrea;
    • Griese, Matthias;
    • Bittmann, Iris;
    • Handgretinger, Rupert;
    • Hartl, Dominik;
    • Rosenecker, Joseph;
    • Rudolph, Carsten
    Publication type:
    Article
    7
    8

    Fabry drug march-in denied.

    Published in:
    Nature Biotechnology, 2011, v. 29, n. 2, p. 97, doi. 10.1038/nbt0211-97b
    By:
    • Ratner, Mark
    Publication type:
    Article
    9

    China calling.

    Published in:
    Nature Biotechnology, 2011, v. 29, n. 2, p. 89, doi. 10.1038/nbt.1784
    Publication type:
    Article
    10
    11
    12

    Natural-born eaters.

    Published in:
    Nature Biotechnology, 2011, v. 29, n. 2, p. 103, doi. 10.1038/nbt.1770
    By:
    • Fox, Jeffrey L.
    Publication type:
    Article
    13
    14

    David Roos.

    Published in:
    2011
    By:
    • Mak, H. Craig
    Publication type:
    Interview
    15
    16
    17

    Gene therapy finds its niche.

    Published in:
    Nature Biotechnology, 2011, v. 29, n. 2, p. 121, doi. 10.1038/nbt.1769
    By:
    • Sheridan, Cormac
    Publication type:
    Article
    18
    19

    Mobile vaccine factories.

    Published in:
    Nature Biotechnology, 2011, v. 29, n. 2, p. 99, doi. 10.1038/nbt0211-99b
    By:
    • Aldridge, Susan
    Publication type:
    Article
    20

    The 2010 Eurobarometer on the life sciences.

    Published in:
    Nature Biotechnology, 2011, v. 29, n. 2, p. 113, doi. 10.1038/nbt.1771
    By:
    • Gaskell, George;
    • Allansdottir, Agnes;
    • Allum, Nick;
    • Castro, Paula;
    • Esmer, Yilmaz;
    • Fischler, Claude;
    • Jackson, Jonathan;
    • Kronberger, Nicole;
    • Hampel, Jurgen;
    • Mejlgaard, Niels;
    • Quintanilha, Alex;
    • Rammer, Andu;
    • Revuelta, Gemma;
    • Stares, Sally;
    • Torgersen, Helge;
    • Wager, Wolfgang
    Publication type:
    Article
    21

    People.

    Published in:
    Nature Biotechnology, 2011, v. 29, n. 2, p. 170, doi. 10.1038/nbt.1781
    Publication type:
    Article
    22

    Synthetic biology go ahead.

    Published in:
    Nature Biotechnology, 2011, v. 29, n. 2, p. 92, doi. 10.1038/nbt0211-92
    By:
    • Eisenstein, Michael
    Publication type:
    Article
    23
    24

    Something new under the skin.

    Published in:
    Nature Biotechnology, 2011, v. 29, n. 2, p. 107, doi. 10.1038/nbt.1768
    By:
    • Eisenstein, Michael
    Publication type:
    Article
    25
    26

    Research highlights.

    Published in:
    Nature Biotechnology, 2011, v. 29, n. 2, p. 140, doi. 10.1038/nbt.1786
    By:
    • Aschheim, Kathy;
    • DeFrancesco, Laura;
    • Elsner, Markus;
    • Hare, Peter;
    • Mak, Craig
    Publication type:
    Article
    27
    28
    29

    Drug pipeline: Q410.

    Published in:
    Nature Biotechnology, 2011, v. 29, n. 2, p. 101, doi. 10.1038/nbt.1776
    By:
    • Peng, Wayne
    Publication type:
    Article
    30
    31

    TALEs of genome targeting.

    Published in:
    Nature Biotechnology, 2011, v. 29, n. 2, p. 135, doi. 10.1038/nbt.1767
    By:
    • Boch, Jens
    Publication type:
    Article
    32

    First public-private vaccine.

    Published in:
    Nature Biotechnology, 2011, v. 29, n. 2, p. 99, doi. 10.1038/nbt0211-99a
    By:
    • Subbaraman, Nidhi
    Publication type:
    Article
    33
    34

    Imperial's £140 million boost.

    Published in:
    Nature Biotechnology, 2011, v. 29, n. 2, p. 96, doi. 10.1038/nbt0211-96b
    By:
    • Rohn, Jennifer
    Publication type:
    Article
    35

    Germany caps drug prices.

    Published in:
    Nature Biotechnology, 2011, v. 29, n. 2, p. 96, doi. 10.1038/nbt0211-96a
    By:
    • Mitchell, Peter
    Publication type:
    Article
    36